American sunscreen is a lie

Quick Overview

American sunscreens lag behind international formulations due to the FDA's stringent and outdated drug-based regulation of UV filters, leading to less effective and less comfortable products compared to those available in Europe and Asia. This regulatory environment, requiring extensive and costly new drug applications for each filter, has resulted in a limited selection of approved ingredients, with the last new filter approved in 1999, while other regions utilize over 30.

Key Points: American sunscreens are considered inferior due to the US FDA regulating them as drugs, a process that significantly slows the approval of new, more effective UV filters compared to cosmetic regulations in Europe and Asia. The US has only 16 approved UV filters, with the last new one approved in 1999, while other regions like the EU have over 30, leading to less comfortable and less comprehensive protection, particularly against UV-A rays. SPF ratings in the US only measure protection against UV-B rays (sunburn) and do not fully reflect UV-A protection, which is crucial for preventing aging and cancer. Dr. Michelle Wong, a cosmetic chemist, states, "The problem is that in Europe and Asia, they have much better ingredients," and notes that "wearability" is a major issue for American sunscreens. International sunscreens, especially Korean brands, gained popularity in the US for their improved formulations, but many were pulled from shelves or reformulated due to US regulations after a 2022 law expanded the FDA's authority. The FDA plans to reduce animal testing requirements and potentially accept safety data from other countries, which could accelerate the approval of new sunscreen ingredients in the US. Christophe quotes, "We are basically living in the sunscreen stone age here in America," reflecting the sentiment that the US is lagging significantly behind other countries in sunscreen technology and availability.

Context: The video investigates why American sunscreens are perceived as inferior to those available internationally, particularly from Asian and European markets. It highlights a significant gap in product quality and comfort, attributing it to the United States' regulatory framework for sunscreens. The host, Christophe, explores the science behind sunscreen and interviews experts to understand the root causes of this disparity, which impacts Americans' ability to protect themselves effectively against rising skin cancer rates.